A recent dispute between an importer and U.S. Customs and Border Protection (CBP) serves as a stark reminder that the “substantial transformation” test used to determine the country of origin of imported goods is far from straightforward.

Suresh Acharya, Professor of Practice at the University of Maryland’s Robert H. Smith School of Business, lays out the challenges of creating an end-to-end supply chain that can produce and distribute millions of doses of a vaccine for COVID-19.

Retailers have a growing number of options to make the best of reverse logistics.  

Ann Marie Uetz, head of the coronavirus task force with the law firm of Foley & Lardner LLP, discusses the results of a pair of surveys about how executives are responding to supply-chain disruptions caused by the pandemic and rising geopolitical tensions.

The coronavirus pandemic has led to severe shortages of personal protective equipment (PPE) needed to protect Americans from the disease. The crisis has revealed an overreliance on imported supplies, particularly from China.

Easier said than done: that pretty well describes the task of shifting manufacturing out of China and back to the United States.